N-Nitrosodimethylamine Contamination in the Metformin Finished Products

A GC–MS/MS method with EI ionization was developed and validated to detect and quantify N-nitrosodimethylamine (NDMA) and seven other nitrosamines in 105 samples of metformin tablets from 13 different manufactures. Good linearity for each compound was demonstrated over the calibration range of 0.5–9...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Molecules (Basel, Switzerland) Ročník 25; číslo 22; s. 5304
Hlavní autoři: Zmysłowski, Adam, Książek, Iza, Szterk, Arkadiusz
Médium: Journal Article
Jazyk:angličtina
Vydáno: Switzerland MDPI 13.11.2020
MDPI AG
Témata:
Calibration
Dimethylnitrosamine - chemistry
Drug Contamination
Drug Design
Europe
Gas Chromatography-Mass Spectrometry
GC-MS
Limit of Detection
Linear Models
metformin
Metformin - analysis
Metformin - chemistry
NDMA
nitrosamines
Pharmaceutical Preparations - analysis
Powders
Solvents
Tablets
Tandem Mass Spectrometry
Temperature
Europe
GC-MS
metformin
nitrosamines
NDMA
ISSN:1420-3049, 1420-3049
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:A GC–MS/MS method with EI ionization was developed and validated to detect and quantify N-nitrosodimethylamine (NDMA) and seven other nitrosamines in 105 samples of metformin tablets from 13 different manufactures. Good linearity for each compound was demonstrated over the calibration range of 0.5–9.5 ng/mL. The assay for all substances was accurate and precise. NDMA was not detected in the acquired active pharmaceutical ingredient (API); however, NDMA was detected in 64 (85.3%) and 22 (91.7%) of the finished product and prolonged finished product samples, respectively. European Medicines Agency recommends the maximum allowed limit of 0.032 ppm in the metformin products. Hence, 28 finished products and 7 pronged dosage products were found to exceed the acceptable limit of daily intake of NDMA contamination. The implications of our findings for the testing of pharmaceutical products are discussed.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1420-3049
1420-3049
DOI:10.3390/molecules25225304